Table II.
Outcomes | N (%) |
---|---|
Best Response | |
CR | 17 (52) |
PR | 6 (18) |
PD | 8 (24) |
SD | 2 (6) |
Proceeded to HDT/SCT | |
No | 18 (55) |
Yes | 15 (45) |
Probability | |
Progression-free survival | |
100 days | 82 (95% CI, 64–91) |
6 months | 67 (95% CI, 48–80) |
1 year | 48 (95% CI, 31–64) |
2 years | 39 (95% CI, 21–57) |
Overall survival | |
100 days | 91 (95% CI, 74–97) |
6 months | 82 (95% CI, 64–91) |
1 year | 67 (95& CI, 48–80) |
2 years | 60 (95% CI, 39–76) |
CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; HDT/SCT, high dose therapy/stem cell transplantation.